Super-sized world: Conference addresses global obesity epidemic, explores policies, interventions

November 29, 2010

A conference at the New York Academy of Sciences on December 9 will convene leading obesity researchers to explore the latest science and policy initiatives addressing the global and national health crisis of obesity. The half-day event, Super-sized World: The Global Obesity Epidemic, is presented by the Academy and the Johns Hopkins Bloomberg School of Public Health with support from the new Sackler Institute for Nutrition Science.

More than one billion adults worldwide are overweight and nearly 300 million are clinically obese, according to the World Health Organization. Obesity is a major contributor to the global burden of chronic disease and disability as a risk factor for type 2 diabetes, cardiovascular disease, hypertension, stroke and certain forms of cancer. Once thought to be a problem affecting only industrialized, developed countries, obesity and obesity-related diseases are increasingly prevalent in the developing world.

Speakers Benjamin Caballero, MD, PhD, of Johns Hopkins Bloomberg School of Public Health, and Jeanne Clark, MD, MHS, of Johns Hopkins University School of Medicine, will give the global and domestic perspectives on obesity, respectively.

Kelly D. Brownell, PhD, of Yale University, will present "The Final Frontier: Is There the Courage to Change Policy," and Keshia M. Pollack, PhD, MPH, of Johns Hopkins Bloomberg School of Public Health, will present "Interventions: Successes, Opportunities, and Challenges."

Robert S. Lawrence, MD, Johns Hopkins Bloomberg School of Public Health, will moderate a panel discussion. A reception will follow the event.

Super-sized World: The Global Obesity Epidemic, takes place from 12:00 - 6:00 PM on Thursday, December 9, 2010, at the New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St., 40th floor, New York, NY.

Registration is $35. Academy members are admitted free. Register online at www.nyas.org/supersized.

Media may register by contacting Adrienne Burke, Director, Public Outreach, the New York Academy of Sciences, at aburke@nyas.org, 212.298.8655.
-end-
About the New York Academy of Sciences

The New York Academy of Sciences is an independent, not-for-profit organization committed to advancing science, technology, and society worldwide since 1817. With 25,000 members in 140 countries, the Academy is creating a global community of science for the benefit of humanity. The Academy's core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large. Please visit us online at www.nyas.org.

New York Academy of Sciences

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.